Norway Savings Bank’s AstraZeneca AZN Stock Holding History

Norway Savings Bank’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,856	Closed	-$341K	–	104
2025 Q4	$341K	Buy	1,856 +210	+13%	+$36.8K	0.16%	90
2025 Q3	$253K	Buy	+1,646	New	+$249K	0.12%	99
2023 Q1	–	Sell	-25	Closed	-$3.39K	–	151
2022 Q4	$3.39K	Hold	25	–	–	﹤0.01%	271
2022 Q3	$3K	Hold	25	–	–	﹤0.01%	265
2022 Q2	$3K	Hold	25	–	–	﹤0.01%	272
2022 Q1	$3K	Sell	25 -50	-67%	-$6K	﹤0.01%	279
2021 Q4	$9K	Buy	75 +25	+50%	+$2.94K	﹤0.01%	263
2021 Q3	$6K	Buy	+50	New	+$5.82K	﹤0.01%	279
2018 Q1	–	Sell	-125	Closed	-$9K	–	247
2017 Q4	$9K	Hold	125	–	–	0.01%	219
2017 Q3	$8K	Hold	125	–	–	0.01%	227
2017 Q2	$9K	Hold	125	–	–	0.01%	223
2017 Q1	$8K	Sell	125 -200	-62%	-$11.6K	0.01%	212
2016 Q4	$18K	Buy	+325	New	+$18.5K	0.02%	188

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Norway Savings Bank's AZN Position: Q1 2026 in Review

Norway Savings Bank sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 1,856 shares — an estimated $341K sold.

Norway Savings Bank first reported a position in AZN in Q4 2016 and held it in 13 quarters. The position peaked at $341K in Q4 2025. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Norway Savings Bank reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
Norway Savings Bank sold 1,856 AstraZeneca shares in Q1 2026, an estimated $341K.
Norway Savings Bank first reported a position in AstraZeneca in Q4 2016 and held it in 13 quarters.
Norway Savings Bank's AstraZeneca position peaked at $341K in Q4 2025.
1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Norway Savings Bank's 13F filing for Q1 2026, filed 20 Apr 2026.